AU2003273502A1 - Metastasis inducing compounds - Google Patents

Metastasis inducing compounds

Info

Publication number
AU2003273502A1
AU2003273502A1 AU2003273502A AU2003273502A AU2003273502A1 AU 2003273502 A1 AU2003273502 A1 AU 2003273502A1 AU 2003273502 A AU2003273502 A AU 2003273502A AU 2003273502 A AU2003273502 A AU 2003273502A AU 2003273502 A1 AU2003273502 A1 AU 2003273502A1
Authority
AU
Australia
Prior art keywords
inducing compounds
metastasis inducing
metastasis
compounds
inducing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003273502A
Other versions
AU2003273502A8 (en
Inventor
Barry Roger Barraclough
Dong Liu
David Ross Sibson
Philip Spencer Rudland
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CLATTERBRIDGE CANCER RESEARCH TRUST
University of Liverpool
Original Assignee
University of Liverpool
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Liverpool filed Critical University of Liverpool
Publication of AU2003273502A1 publication Critical patent/AU2003273502A1/en
Publication of AU2003273502A8 publication Critical patent/AU2003273502A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3015—Breast
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A01K2267/0331—Animal model for proliferative diseases
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/16—Primer sets for multiplex assays

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Hospice & Palliative Care (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
AU2003273502A 2002-10-02 2003-10-02 Metastasis inducing compounds Abandoned AU2003273502A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0222787.4 2002-10-02
GBGB0222787.4A GB0222787D0 (en) 2002-10-02 2002-10-02 Metastasis inducing compounds
PCT/GB2003/004279 WO2004031239A2 (en) 2002-10-02 2003-10-02 Metastasis inducing compounds

Publications (2)

Publication Number Publication Date
AU2003273502A1 true AU2003273502A1 (en) 2004-04-23
AU2003273502A8 AU2003273502A8 (en) 2004-04-23

Family

ID=9945131

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003273502A Abandoned AU2003273502A1 (en) 2002-10-02 2003-10-02 Metastasis inducing compounds

Country Status (3)

Country Link
AU (1) AU2003273502A1 (en)
GB (1) GB0222787D0 (en)
WO (1) WO2004031239A2 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006061418A2 (en) * 2004-12-09 2006-06-15 Ingenium Pharmaceuticals Ag Methods and agents useful in treating conditions characterized by mucus hyperproduction/hypersecretion
GB0616929D0 (en) 2006-08-26 2006-10-04 Univ Liverpool Antibodies, assays and hybridomas
EP2078203A1 (en) * 2006-08-29 2009-07-15 Oxford Genome Sciences (UK) Limited Protein
KR100982186B1 (en) * 2010-01-21 2010-09-14 전남대학교산학협력단 Novel tumor antigen protein agr2 and tumor antigenpeptide thereof
US9415088B2 (en) 2011-02-25 2016-08-16 The Board Of Trustees Of The Leland Stanford Junior University Use of AGR3 for treating cancer
CN102268089A (en) * 2011-07-05 2011-12-07 上海交通大学 AGR2 (Anterior Gradient-2) blocking antibody and application thereof
EP3077528B1 (en) * 2013-12-02 2018-08-22 Albert-Ludwigs-Universität Freiburg Process for the diagnosis of cancer by using exosomes
US20190016821A1 (en) * 2016-01-08 2019-01-17 Temple University Of The Commonwealth System Of Higher Education Stabilized peptide fragments from protocadherin fat1 as cancer biomarkers
CN109576229A (en) * 2018-12-13 2019-04-05 华中科技大学同济医学院附属协和医院 A kind of monoclonal antibody hybridoma cell strain and its application for secreting anti-AGR2

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002508652A (en) * 1996-08-23 2002-03-19 ヒューマン ジノーム サイエンシーズ，インコーポレイテッド Novel human growth factor
WO1998041627A1 (en) * 1997-03-19 1998-09-24 Zymogenetics, Inc. Secreted polypeptides with homology to xenopus cement gland proteins
US6528054B1 (en) * 1998-12-28 2003-03-04 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
GB0004576D0 (en) * 2000-02-25 2000-04-19 Oxford Glycosciences Uk Ltd Proteins
US6974667B2 (en) * 2000-06-14 2005-12-13 Gene Logic, Inc. Gene expression profiles in liver cancer
GB0023080D0 (en) * 2000-09-20 2000-11-01 Univ Liverpool Prognostic indicator
CA2440703A1 (en) * 2001-01-24 2002-08-01 Protein Design Labs, Inc. Methods of diagnosis of breast cancer, compositions and methods of screening for modulators of breast cancer

Also Published As

Publication number Publication date
WO2004031239A2 (en) 2004-04-15
GB0222787D0 (en) 2002-11-06
AU2003273502A8 (en) 2004-04-23
WO2004031239A3 (en) 2004-05-27

Similar Documents

Publication Publication Date Title
AU2003266949A1 (en) Compounds
AU2003221098A1 (en) Oligofluorenylene compounds
AU2003287136A1 (en) Novel compounds having selective inhibiting effect at gsk3
GB0202216D0 (en) Novel compounds
AU2003279366A1 (en) Novel compounds
GB0202679D0 (en) Novel compounds
AU2003216859A1 (en) Amidoacetonitrile compounds
AU2003273502A1 (en) Metastasis inducing compounds
GB0203299D0 (en) Novel compounds
AU2003251259A1 (en) Novel compounds
AU2003292667A1 (en) Benzocycloheptapyridine compounds
GB0200025D0 (en) Novel compounds
AU2003255322A1 (en) Compounds
AU2003275480A1 (en) Compounds
AU2002950855A0 (en) Materials
AU2003226541A1 (en) Novel compounds
GB0222788D0 (en) Metastasis inducing compounds
AU2003900207A0 (en) New compounds
AU2002953602A0 (en) New compounds
AU2002951547A0 (en) New compounds
AU2003904509A0 (en) Novel Compounds
AU2003901012A0 (en) Novel compounds
AU2003904500A0 (en) Novel compounds II
AU2003903928A0 (en) New compounds
AU2003901804A0 (en) New compounds

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase